Oncology and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 55.9% | 1.159 | Q2 | 87.3% |
| 2024 | 3.2 | Q2 | 60.7% | 1.330 | Q1 | 90.3% |
| 2023 | 3.2 | Q2 | 57.1% | 0.898 | Q2 | 82.8% |
| 2022 | 2.7 | 36.9% | 0.817 | Q2 | 81.1% | |
| 2021 | — | 25.2% | 0.130 | Q4 | 25.8% | |
| 2020 | — | — | 0.125 | Q4 | 12.9% | |
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2366-1089
ISSN
2366-1070
region
Western Europe
coverage
2016-2026